Fuse Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
March 31, 2021 at 06:25 am EDT
Share
Fuse Medical, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was USD 21.398 million compared to USD 22.900 million a year ago. Operating loss was USD 1.027 million compared to USD 4.349 million a year ago. Net loss was USD 1.432 million compared to USD 3.316 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.05 a year ago.
Fuse Medical, Inc. is a manufacturer and distributor of medical devices in the United States. The Company provides a range of a portfolio of orthopedic implants, including foot and ankle, orthopedics, sports medicine and spine. It also provides a range of osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. Its foot and ankle product offerings include internal and external fixation for forefoot, midfoot and hindfoot reconstruction. Its orthopedics offer joint reconstruction systems for upper and lower extremities, which include the sterizo total knee, tibial revision, and total hip replacement systems, as well as the arrow total and reverse total shoulder system. Its sports medicine offers a line of fuse suture anchors and interference screws, as well as multiple products for soft tissue fixation augmentation. Its spine offers spinal products for cervical and thoracolumbar fusion.
FUSE MEDICAL, INC. 
